FDA Import Refusal 1FX-0455126-4/40002/1 — Cipla Pvt Ltd

Cipla Pvt Ltd — FEI 3012215569

The FDA refused shipment 1FX-0455126-4/40002/1 from Cipla Pvt Ltd (India) on Aug 25, 2026. The refused product falls under Drugs and Biologics — ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Aug 25, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
61JCA08 ATORVASTATIN CALCIUM (ANTI-CHOLESTEREMIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.